Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity
Authors:
- Matthijs BaarsMBMatthijs Baars
- Thera DoumaTDThera Douma
- Dimitre R. SimeonovDSDimitre R. Simeonov
- Darienne R. MyersDMDarienne R. Myers
- Saikat BanerjeeSBSaikat Banerjee
- Kayla KulhanekKKKayla Kulhanek
- Susan ZwakenbergSZSusan Zwakenberg
- Marijke P. BaltissenMBMarijke P. Baltissen
- Sytze de RoockSRSytze de Roock
- Femke van WijkFWFemke van Wijk
- Michiel VermeulenMVMichiel Vermeulen
- Alexander MarsonAMAlexander Marson
Preprint
Abstract
RasGRP1 is a Ras guanine nucleotide exchange factor, and an essential regulator of lymphocyte receptor signaling. In mice, Rasgrp1 deletion results in defective T lymphocyte development. RASGRP1 -deficient patients suffer from immune deficiency, and the RASGRP1 gene has been linked to autoimmunity. However, how RasGRP1 levels are regulated, and if RasGRP1 dosage alterations contribute to autoimmunity remains unknown. We demonstrate that diminished Rasgrp1 expression caused defective T lymphocyte selection in C57BL/6 mice, and that the severity of inflammatory disease inversely correlates with Rasgrp1 expression levels. In patients with autoimmunity, active inflammation correlated with decreased RASGRP1 levels in CD4 + T cells. By analyzing H3K27 acetylation profiles in human T cells, we identified a RASGRP1 enhancer that harbors autoimmunity-associated SNPs. CRISPR-Cas9 disruption of this enhancer caused lower RasGRP1 expression, and decreased binding of RUNX1 and CBFB transcription factors. Analyzing patients with autoimmunity, we detected reduced RUNX1 expression in CD4 + T cells. Lastly, we mechanistically link RUNX1 to transcriptional regulation of RASGRP1 to reveal a key circuit regulating RasGRP1 expression, which is vital to prevent inflammatory disease.Keywords
All Related Versions
- Published version: European Journal of Immunology, 51 (2), 471.
This publication has 43 references indexed in Scilit:
- Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitorsArthritis Research & Therapy, 2015
- Genetic and epigenetic fine mapping of causal autoimmune disease variantsNature, 2014
- Easy quantitative assessment of genome editing by sequence trace decompositionNucleic Acids Research, 2014
- Rasgrp1 mutation increases naïve T-cell CD44 expression and drives mTOR-dependent accumulation of Helios+ T cells and autoantibodieseLife, 2013
- Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell LeukemogenesisScience Signaling, 2013
- RasGRP1, but Not RasGRP3, Is Required for Efficient Thymic β-Selection and ERK Activation Downstream of CXCR4PLOS ONE, 2013
- Multiplex peptide stable isotope dimethyl labeling for quantitative proteomicsNature Protocols, 2009
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- RasGRP1 and RasGRP3 Regulate B Cell Proliferation by Facilitating B Cell Receptor-Ras SignalingThe Journal of Immunology, 2005
- RasGRP is essential for mouse thymocyte differentiation and TCR signalingNature Immunology, 2000